MoleculeMind Unveils QuantaMind to Simulate Atomic-Scale Reactions

Traditional molecular dynamics often forces a compromise between computational speed and chemical precision. While classical force fields handle large systems, they fail to capture critical events like bond breaking or proton transfer. Conversely, quantum mechanical methods like DFT provide necessary accuracy but remain too resource-intensive for complex biomolecular environments. QuantaMind bridges this divide by using a transition-state-centered machine learning force field that incorporates non-equilibrium conformations into its training data.

The platform has already demonstrated industrial utility, notably in enzyme engineering and the development of pH-sensitive antibodies. In one case study, researchers identified a candidate with a dissociation rate 62 times faster at pH 6.0 than at pH 7.4. According to MoleculeMind founder Xu Jinbo, the goal is to provide a verifiable, mechanistic backbone for drug discovery that moves beyond simple structure prediction. Capable of processing a 100,000-atom system in 0.25 seconds per time-step, the technology offers a pathway to guide mutation selection through simulation rather than trial and error.